Operating

Lease impairment charges

Roivant Sciences Lease impairment charges remained flat by 0.0% to $3.90M in Q1 2026 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementCash Flow Statement
SectionOperating
CategoryEfficiency
SignalLower is better
VolatilityModerate
First reportedQ1 2023
Last reportedQ4 2025May 20, 2026

How to read this metric

An increase indicates potential underutilization of leased space or assets, signaling operational inefficiency or a shift in real estate strategy.

Detailed definition

This represents non-cash charges recognized when the carrying amount of an operating lease right-of-use asset exceeds it...

Peer comparison

Common in companies with large physical footprints or significant office/lab space portfolios.

Metric ID: operating_operating_lease_impairment_loss

Historical Data

9 periods
 Q1 '23Q2 '23Q3 '23Q4 '23Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Value$0.00$0.00$0.00$0.00$0.00$3.90M$3.90M$3.90M$3.90M
QoQ Change+0.0%+0.0%+0.0%
Range$0.00$3.90M
Current Streak3+ quarters growth

Lease impairment charges at Other Companies

Frequently Asked Questions

What is Roivant Sciences's lease impairment charges?
Roivant Sciences (ROIV) reported lease impairment charges of $3.90M in Q1 2026.
What does lease impairment charges mean?
A non-cash expense reflecting a reduction in the value of leased assets.